Company information ......................................................................................................................................................... | |
Strategic report ................................................................................................................................................................... | |
Directors’ report .................................................................................................................................................................... | |
Statement of directors’ responsibilities ....................................................................................................................... | |
Independent auditors report to the members of Semperian Senior Funding plc ....................................... | |
Profit and Loss Account for the year ended 31 March 2026 ............................................................................... | |
Statement of changes in equity ...................................................................................................................................... | |
Statement of financial position ....................................................................................................................................... | |
Notes to the financial statements .................................................................................................................................. |
Year ended 31 March 2026 | Year ended 31 March 2025 | ||||
Note | £ | £ | |||
Administrative expenses | ( | ( | |||
Other operating income | 5 | ||||
Operating profit | |||||
Interest receivable and similar income | 2 | ||||
Interest payable and similar expenses | 3 | ( | ( | ||
Net interest expense | ( | ( | |||
Movement in fair value of derivative financial instruments | 4 | ||||
Profit before taxation | |||||
Tax on profit | 8 | ( | ( | ||
Profit for the financial year |
Called up share capital | Profit and loss account | Total shareholders' funds | |||
£ | £ | £ | |||
Balance as at 1 April 2024 | 12,502 | 3,206,686 | 3,219,188 | ||
Profit for the year | — | 522,867 | 522,867 | ||
Balance as at 31 March 2025 | 12,502 | 3,729,553 | 3,742,055 | ||
Profit for the year | — | 241,485 | 241,485 | ||
Balance as at 31 March 2026 | 12,502 | 3,971,038 | 3,983,540 |
31 March | 31 March | ||||
2026 | 2025 | ||||
Note | £ | £ | |||
Fixed assets | |||||
Loans | 9 | ||||
Current assets | |||||
Derivatives measured at fair value | 4 | ||||
Debtors: Amount falling due within one years | 10 | ||||
Cash at bank and in hand | |||||
19,175,133 | 20,605,651 | ||||
Creditors: amounts falling due within one year | 11 | ( | ( | ||
Net current assets | |||||
Total assets less current liabilities | |||||
Creditors: amounts falling due after more than one year | 11 | ( | ( | ||
Net assets | |||||
Capital and reserves | |||||
Called up share capital | 12 | ||||
Profit and loss account | 13 | ||||
Total shareholders' funds |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||
£ | £ | |||
Loan interest | 2,709,508 | 4,013,669 | ||
Bank interest | 40,023 | 70,237 | ||
2,749,531 | 4,083,906 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||
£ | £ | |||
Interest expense on Notes | 2,517,518 | 4,056,496 | ||
Amortisation of issue costs | 438,945 | 455,165 | ||
Net amounts payable in respect of interest rate and cross currency swap contracts | 182,893 | 401,065 | ||
3,139,356 | 4,912,726 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||
£ | £ | |||
Brought forward fair value of interest rate and currency swap contracts | 3,719,274 | 3,196,611 | ||
Fair value movement during the year on swap contracts | 241,327 | 522,663 | ||
Carried forward fair value of interest rate and currency swap contracts | 3,960,601 | 3,719,274 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||
£ | £ | |||
Profit appropriation | 601,266 | 988,465 | ||
Fees received | 42,840 | 92,182 | ||
644,106 | 1,080,647 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||
£ | £ | |||
Auditors' remuneration - audit services | 19,650 | 17,775 | ||
Amortisation of issue costs | 438,945 | 455,165 | ||
458,595 | 472,940 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||
£ | £ | |||
a) Analysis of the company charge in the year | ||||
UK corporation tax charge on the profit for the year at an effective rate of 25.00% (2025: 25.00%) | 53 | 68 | ||
53 | 68 | |||
b) Factors affecting the company tax charge for the year | ||||
The tax charge for the year is lower than the standard rate of corporation tax in the UK of 25% (2025: lower than the standard rate of 25%) | ||||
Year ended 31 March 2026 | Year ended 31 March 2025 | |||
£ | £ | |||
Profit before taxation | 241,538 | 522,935 | ||
Current tax charge at an effective rate of 25.00% (2025: 25.00%) | 60,385 | 130,734 | ||
Effects of: | ||||
Income not taxable | (60,385) | (130,734) | ||
Tax payable under Securitisation Companies Regulations | 53 | 68 | ||
Total tax charge | 53 | 68 |
31 March 2026 | 31 March 2025 | |||
£ | £ | |||
Opening balance | 55,389,902 | 72,301,407 | ||
Redemptions during the year | (15,227,623) | (16,911,505) | ||
Closing balance | 40,162,279 | 55,389,902 | ||
Net book value as at 31 March | 40,162,279 | 55,389,902 | ||
The maturity profile of the Loans was as follows: | ||||
In one year or less | 13,713,342 | 15,000,495 | ||
In more than one year | 26,448,937 | 40,389,407 | ||
40,162,279 | 55,389,902 |
31 March 2026 | 31 March 2025 | |||
£ | £ | |||
Amounts falling due within one year | ||||
Loans due within one year (see note 9) | 13,713,342 | 15,000,495 | ||
Other debtors | 208 | 208 | ||
Prepayments and accrued income | 5,837 | 20,726 | ||
13,719,387 | 15,021,429 |
31 March 2026 | 31 March 2025 | |||
£ | £ | |||
Amounts falling due within one year | ||||
Notes | 13,142,876 | 15,000,495 | ||
Other Creditors | 441,009 | 773,655 | ||
Corporation Tax | 53 | 68 | ||
Z Notes | — | 117,000 | ||
13,583,938 | 15,891,218 |
31 March 2026 | 31 March 2025 | |||
£ | £ | |||
Amounts falling due after more than one year | ||||
Notes | 30,732,519 | 43,875,390 | ||
Issue costs | (5,420,091) | (5,859,035) | ||
Z Notes | 50,000 | 50,000 | ||
Other Creditors | 2,694,164 | 3,295,430 | ||
28,056,592 | 41,361,785 |
31 March 2026 | 31 March 2025 | |||
£ | £ | |||
Called up, allotted and issued | ||||
49,998 ordinary shares of £1 each - quarter paid | 12,500 | 12,500 | ||
2 ordinary shares (2025: 2) of £1 each fully paid | 2 | 2 | ||
12,502 | 12,502 |
31 March 2026 | 31 March 2025 | |||
£ | £ | |||
Opening balance | 3,729,553 | 3,206,686 | ||
Profit for the financial year | 241,485 | 522,867 | ||
Closing balance | 3,971,038 | 3,729,553 |
% control by Semperian PPP Investment Partners Holdings Limited | Closing balances as at 31 March | Interest payable in the year to the Company | |
Maturity Timeline | % | £ | £ |
2026 | |||
Defence Training Services Ltd | 50% | 7,473,089 | 813,670 |
2025 | |||
Defence Training Services Ltd | 50% | 14,339,843 | 1,289,727 |
Mercia Healthcare Ltd | 75% | — | 4,522 |